+140.0%
ASML vs BBIO
+191.8%
-51.8%
-45.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.8% | +1.1% | +0.7% | +1.6% |
| 7D | +2.5% | +2.1% | +0.4% | +2.2% |
| 30D | -12.2% | +21.0% | -33.2% | -15.1% |
| 3M | -14.6% | -5.0% | -9.6% | -14.0% |
| 6M | -1.7% | +23.0% | -24.7% | -5.8% |
| YTD | +44.3% | +4.0% | +40.3% | +41.5% |
| 1Y | +51.0% | +19.5% | +31.5% | +44.7% |
| All | +140.0% | +191.8% | -51.8% | +90.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling